Key terms
About CMMB
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest CMMB news
Apr 18
7:07am ET
Chemomab Therapeutics reports publication on its CCL24 target, SSc
Mar 25
7:21am ET
Chemomab Therapeutics awarded European patent for CM-101
Feb 20
7:20am ET
Chemomab Therapeutics awarded new patents for CM-101 in Brazil and Israel
Jan 30
7:16am ET
Chemomab Therapeutics’ CM-101 shows clinical potential in sclerosing cholangitis
No recent press releases are available for CMMB
CMMB Financials
Key terms
Ad Feedback
CMMB Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
CMMB Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range